SCHEMBL4959965

SCHEMBL4959965

C=[C]CNCC(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL112567 0.73 TSHR (0.36)
SCHEMBL12788412 0.71
SCHEMBL4625077 0.71
SCHEMBL13472106 0.71
Fluoride SCHEMBL22032650 0.70 TSHR (0.33)
Hydrochloric Acid SCHEMBL4316309 0.70 TSHR (0.33)
Hydrochloric Acid SCHEMBL4662388 0.70 TSHR (0.33)
SCHEMBL1669502 0.69
SCHEMBL22247230 0.67 TSHR (0.31)
SCHEMBL26537553 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1656355-B1 PIPERAZINE DERIVATIVES AND METHODS OF USE AMGEN INC (US) 2008-03-12 EP disclosed
EP-1878728-A2 Derivatives of piperazine and higher homologues thereof for the treatment of inflammation-related disorders Amgen Inc. (US) 2008-01-16 EP disclosed